Toujeo Injection, Solution
Product Images NDC 50090-2193

Product Visual Gallery

This gallery contains 51 technical images submitted to the FDA as part of the official labeling for Toujeo (NDC 50090-2193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500902193)

Label for TOUJEO insulin glargine injection, 300 units/mL, by A-S Medication Solutions. The label states it is for single-patient use only and includes storage instructions to keep refrigerated between 36 to 46 degrees Fahrenheit. The package contains 3 prefilled pens with a total of 450 units (150 units each).*

FDA Label Image

Chemical Structure (Toujeo 01)

Chemical structure diagram showing the A and B chains of insulin glargine, with amino acids labeled in sequence and disulfide bonds indicated between cysteine residues.*

FDA Label Image

Figure 1 (Toujeo 02)

A line graph depicting the glucose infusion rate (GIR) in mg/kg*min over time in hours after subcutaneous injection of TOUJEO insulin glargine 0.4 units/kg. The x-axis represents time up to 36 hours, with a vertical dashed line at 24 hours. The graph shows GIR changes post-injection.*

FDA Label Image

Figure (Toujeo 03)

Illustration showing recommended subcutaneous injection sites on the human body for insulin glargine. Highlighted areas include the upper arms, stomach, and thighs. Labels indicate the specific injection locations on a front-view human figure.*

FDA Label Image

Figure (Toujeo 04)

An illustrated diagram of the TOUJEO insulin glargine injection pen showing labeled parts: pen cap, cartridge holder with rubber seal and insulin scale, plunger (not visible until after dose injection), dose window with dose pointer, dose selector, and injection button. The pen label displays product name and 300 Units/mL concentration for subcutaneous use.*

FDA Label Image

Figure (Toujeo 05)

TOUJEO 300 Units/mL injection pen label showing insulin glargine solution for subcutaneous use. The label includes the brand name, concentration, and usage instruction 'for single patient use only.' The product is supplied by A-S Medication Solutions.*

FDA Label Image

Figure (Toujeo 06)

TOUJEO 300 U/mL insulin glargine injection solution in a pen device. The label includes a lot number and expiration date (2029-10-31) visible on the pen barrel. The pen has a white body with green and gray accents and a QR code near the lot and expiration information. Labeler is A-S Medication Solutions.*

FDA Label Image

Figure (Toujeo 07)

An instructional diagram showing how to remove the outer needle cap from a Toujeo insulin glargine 300 U/mL injection pen. The image depicts two hands holding the pen and pulling the needle cap straight off with a blue arrow indicating the direction.*

FDA Label Image

Figure (Toujeo 08)

TOUJEO insulin glargine 300 U/mL injection solution in a subcutaneous delivery pen. The image shows the pen device with a green body and a partially visible label featuring a pattern of blue, green, and yellow dots. The NDC and labeler A-S Medication Solutions are provided in the product data but not visible on the image.*

FDA Label Image

Figure (Toujeo 09)

An instructional illustration showing hands peeling back a paper label from a small green vial or cartridge, likely demonstrating preparation steps for subcutaneous injection.*

FDA Label Image

Figure (Toujeo 10)

An illustration showing two hands holding an insulin cartridge. One hand grips the cartridge while the other is removing a gray cap from the cartridge tip, demonstrating how to prepare the injection solution for use.*

FDA Label Image

Figure (Toujeo 11)

Instructional illustration showing proper removal of the cap from a TOUJEO insulin glargine injection pen before use. The image depicts one hand holding the pen and the other hand twisting and pulling the cap off in a clockwise direction. An inset highlights improper cap removal by pulling straight off without twisting, marked with a red prohibition symbol.*

FDA Label Image

Figure (Toujeo 12)

An instructional illustration showing two hands: one holding an insulin pen with a visible measurement scale on the dosing window, and the other hand removing a small protective cap from the pen needle, demonstrating preparation for subcutaneous injection.*

FDA Label Image

Figure (Toujeo 13)

An instructional illustration showing hands preparing an injection. One hand holds a prefilled syringe labeled '300', and the other hand is shown removing a cap from a vial or bottle, indicating preparation for subcutaneous injection of insulin glargine solution.*

FDA Label Image

Figure (Toujeo 14)

An instructional illustration showing a hand holding a Toujeo 300 U/mL insulin glargine injection pen. The image highlights adjusting the dose by rotating the dose selector on the pen, with a close-up detail indicating the selector dial set between 2 and 4 units.*

FDA Label Image

Figure (Toujeo 15)

An instructional diagram illustrating how to prime a syringe pen injection device. It shows a hand holding the injection pen with the needle pointing upward and an arrow indicating to press the injection button to release a spray of medication from the needle tip.*

FDA Label Image

Figure (Toujeo 16)

TOUJEO SoloStar insulin glargine injection pen, 300 Units/mL concentration. The pen shows dose markings on the barrel up to 80 units, and the label indicates it is a single-patient use subcutaneous injection. The labeler is A-S Medication Solutions.*

FDA Label Image

Figure (Toujeo 17)

An instructional illustration showing hands holding a TOUJEO insulin glargine injection pen. The image guides the user to turn the dose knob on the pen, indicated by a blue arrow, presumably to dial or adjust the insulin dose before injection.*

FDA Label Image

Figure (Toujeo 18)

An illustration showing a close-up view of the dose selector window on a Toujeo insulin glargine 300 U/mL injection device, displaying a dosing increment scale with numbers 28, 30, and 32 visible.*

FDA Label Image

Figure (Toujeo 19)

An illustration showing a close-up view of a dial mechanism with numbers 28 to 30 visible, likely representing dose settings on an injection device for insulin glargine.*

FDA Label Image

Figure (Toujeo 20)

An instructional illustration showing a hand holding a TOUJEO insulin glargine injection pen, positioned for subcutaneous administration. The image depicts the needle being inserted into the skin, indicated by a blue arrow pointing towards the injection site.*

FDA Label Image

Figure (Toujeo 21)

An instructional illustration showing the correct method to adjust the dose on a TOUJEO insulin glargine injection pen. The hand holds the pen with a close-up of the dose dial, indicating to turn the dial to the correct dosage number with a blue arrow, while a red circle with a line through it shows an incorrect method of dialing the dose.*

FDA Label Image

Figure (Toujeo 22)

An instructional diagram illustrating proper use of the TOUJEO (insulin glargine) injection pen. The image shows a hand holding the pen at the injection site on the arm, highlighting pressing the injection button and holding it in place for 5 seconds to ensure full dose delivery by subcutaneous injection.*

FDA Label Image

Figure (Toujeo 23)

An instructional illustration showing two hands handling an injection pen device, with the right hand removing the pen cap by pulling it straight off as indicated by a blue arrow pointing to the right.*

FDA Label Image

Figure (Toujeo 24)

An instructional diagram showing how to remove the cap from a prefilled insulin glargine injection pen, TOUJEO, 300 U/mL. The image depicts hands holding the pen and using a twisting motion and finger pressure to remove the pen cap before subcutaneous injection.*

FDA Label Image

Figure (Toujeo 25)

An instructional illustration showing a pair of hands removing a silver foil seal from a bottle and inserting a small cap or stopper into the bottle's opening. The blue arrow indicates the sequence of actions, demonstrating how to remove the seal and place the cap properly on the bottle.*

FDA Label Image

Toujeo 26

An instructional illustration showing a hand gripping an insulin pen cartridge labeled TOUJEO insulin glargine 300 units/mL while inserting it into an injection pen device, indicated by a blue arrow pointing toward the pen.*

FDA Label Image

Toujeo 27

An illustration diagram showing recommended subcutaneous injection sites on a human body for insulin administration. Highlighted areas in green include the upper arms, stomach, and thighs, indicating appropriate locations for subcutaneous injections such as insulin glargine.*

FDA Label Image

Toujeo 28

An instructional diagram of the Toujeo Max SoloStar insulin glargine injection pen showing labeled parts including pen cap, cartridge holder, rubber seal, insulin scale, plunger, dose window, dose pointer, dose selector, and injection button. It notes the insulin concentration as 300 Units/mL and highlights patient-use features.*

FDA Label Image

Toujeo 29

TOUJEO Max SoloStar insulin glargine injection 300 U/mL pen label for single patient use only. The label includes dosing information, indicating adjustment by 2 units. The labeler is A-S Medication Solutions.*

FDA Label Image

Toujeo 30

The image shows a TOUJEO injection pen containing insulin glargine 300 U/mL solution for subcutaneous use. The pen has a beige body with a green and black patterned band near the label area. The lot number is 123XY and the expiration date is 2029-10-31. The pen has a white cap on one end and a green dose selector on the other. The labeler is A-S Medication Solutions.*

FDA Label Image

Toujeo 31

An instructional illustration showing hands assembling or preparing a TOUJEO insulin glargine injection pen. The image depicts the alignment of the pen components, with an arrow indicating the direction to push or connect parts for proper assembly before subcutaneous injection.*

FDA Label Image

Toujeo 32

An illustration showing a close-up section of a TOUJEO 300 Units/mL insulin glargine injection pen, focusing on the dosing window and part of the pen body with a label indicating the strength.*

FDA Label Image

Toujeo 33

An illustration showing hands cleaning the metal tip of a pen injector device with a cloth or tissue. The image emphasizes proper maintenance or hygiene of the injection device used for subcutaneous administration.*

FDA Label Image

Toujeo 34

Illustration showing hands holding and separating a small vial cap or seal, likely demonstrating the removal or preparation step for using an injectable medication vial.*

FDA Label Image

Toujeo 35

Instructional diagram showing how to remove the cap from a TOUJEO 300 U/mL insulin glargine injection pen. The illustration depicts a hand twisting and pulling the pen cap off with a directional blue arrow, and an inset circle with a red arrow highlighting careful removal to avoid damage.*

FDA Label Image

Toujeo 36

An instructional illustration showing a hand holding a TOUJEO (insulin glargine) injection pen and another hand about to place or remove a small cap on a vial or pen needle. The pen displays dosage markings typical for insulin delivery.*

FDA Label Image

Toujeo 37

An instructional illustration showing a hand removing the cap from a vial or container, with a syringe positioned nearby. The syringe is marked with measurement units, indicating preparation for injection or medication withdrawal.*

FDA Label Image

Toujeo 38

An instructional illustration showing a hand adjusting the dose on a Toujeo SoloStar injection pen. A close-up inset highlights the dose selector with 4 units selected, demonstrating dose adjustment on the insulin glargine prefilled pen device.*

FDA Label Image

Toujeo 39

An instructional illustration depicting a hand holding a TOUJEO insulin glargine 300 U/mL injection pen. The image highlights the needle tip with a zoomed-in circle showing fluid being expelled, demonstrating the priming or air removal step before subcutaneous injection.*

FDA Label Image

Toujeo 40

TOUJEO Max SoloStar insulin glargine injection pen delivers 300 Units/mL of solution for subcutaneous use. The label shows a dose selector with graduated dose markings up to 80 units, the product name, strength, and indication that it is for single patient use. It is labeled by A-S Medication Solutions.*

FDA Label Image

Toujeo 41

An instructional illustration showing a person adjusting the dose on a Toujeo SoloStar injection pen. The person's thumb is turning the dose selector dial to increase the dose by 2 units, indicated by a blue arrow and a displayed dose number.*

FDA Label Image

Toujeo 42

Close-up of a dose selector window on TOUJEO 300 U/mL insulin glargine injection pen, showing dose numbers on the dial used for subcutaneous injection. The image highlights the pen's mechanical dosing mechanism, associated with the A-S Medication Solutions labeler.*

FDA Label Image

Toujeo 43

A close-up illustration of a dial or display window showing the numbers 56 and 60, likely representing a dosage setting or measurement indicator on a medical device or pen injector.*

FDA Label Image

Toujeo 44

Illustration showing the proper technique to hold and inject the TOUJEO insulin glargine 300 U/mL injection pen subcutaneously. The hand grips the pen with the thumb on the injection button and an arrow indicates the direction for injecting dosage into the skin.*

FDA Label Image

Toujeo 45

An instructional illustration showing the proper method to adjust the dose knob on a Toujeo (insulin glargine) injection pen. The image highlights with a blue circle and arrow the correct way to grip and turn the dose selector, and with a red circle and cross the incorrect way to turn it. The pen is shown held in a hand with focus on the dose selector window marked with numbers.*

FDA Label Image

Toujeo 46

Illustration showing the proper method for subcutaneous injection of TOUJEO (insulin glargine) 300 U/mL. The image depicts a hand holding the injection pen against the skin, with a close-up inset highlighting that the needle should be held in place for 5 seconds after injection to ensure full delivery of the dose.*

FDA Label Image

Toujeo 47

An instructional illustration showing a hand holding a TOUJEO (insulin glargine) 300 U/mL injection pen. A second hand is shown pulling the pen's needle cap straight off, indicated by a blue arrow pointing to the right.*

FDA Label Image

Toujeo 48

Illustration showing a person holding a Toujeo insulin glargine 300 U/mL injection pen, demonstrating how to twist the pen cap for use. The pen displays a dosage scale with markings from 100 to 900 units.*

FDA Label Image

Toujeo 49

An instructional illustration depicting hands removing a cap from a vial or bottle, with an arrow indicating the removal direction. The image suggests a step in the preparation or administration of a medication solution for injection.*

FDA Label Image

Toujeo 50

An instructional illustration showing hands holding an injection pen labeled TOUJEO insulin glargine 300 U/mL. The diagram indicates the removal of the pen cap by pulling it straight off, as depicted by a blue arrow pointing away from the pen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.